von Hippel-Lindau disease

• 

What is genetic testing for cancer?

By Sharon Kell|2021-01-11T09:48:33+00:0011 Jan 2021|Cancer news|

This article gives a good summary of the use of [...]

Read More

Comments Off on What is genetic testing for cancer?

• 

ESMO Virtual 2020: HIF-2a MK-6482 in Von Hippel-Lindau Disease and kidney cancer

By Sharon Kell|2020-09-21T09:41:33+00:0021 Sep 2020|Uncategorized|

At the European Society of Medical Oncology (ESMO) Virtual Congress [...]

Read More

Comments Off on ESMO Virtual 2020: HIF-2a MK-6482 in Von Hippel-Lindau Disease and kidney cancer

• 

ASCO 2020: HIF-2 alpha inhibitor induced positive response for VHL-associated kidney cancer

By Sharon Kell|2020-06-02T09:12:44+00:002 Jun 2020|Uncategorized|

Results from a phase II international trial led by researchers [...]

Read More

Comments Off on ASCO 2020: HIF-2 alpha inhibitor induced positive response for VHL-associated kidney cancer

• 

VHL disease and HIF-2alpha inhibitor

By Sharon Kell|2020-01-06T11:50:50+00:006 Jan 2020|Drug treatments|

In this video interview, Dr Eric Jonasch from MD Anderson [...]

Read More

Comments Off on VHL disease and HIF-2alpha inhibitor

• 

Pazopanib for the treatment of von Hippel-Lindau disease

By Sharon Kell|2017-06-06T13:37:29+00:006 Jun 2017|Drug treatments|

The results from a phase II clinical trial, which demonstrates [...]

Read More

Comments Off on Pazopanib for the treatment of von Hippel-Lindau disease